Sandbox Reserved 1710
From Proteopedia
(Difference between revisions)
Line 28: | Line 28: | ||
== Disease and Medical Relevance == | == Disease and Medical Relevance == | ||
- | Currently over 1485 mutations of Neurofibromin have been identified that lead to life-threatening illnesses or conditions such as Neurofibromatosis Type I.<ref name="Lupton">PMID: 34887559 </ref> <ref name="Abramowicz">PMID:25182393</ref> Mutations to the NF1 gene that prevents the interaction of Neurofibromin with Ras, remove this check on Ras-dependent cell proliferation and uncontrolled cell growth can lead to tumors and a higher risk of cancer. [https://en.wikipedia.org/wiki/Neurofibromatosis_type_I Neurofibromatosis Type 1], the most well-known disease resulting from mutations in Neurofibromin, is characterized by cognitive impairment, soft, non-cancerous tumors on or under the skin known as neurofibromas, birthmarks called [https://en.wikipedia.org/wiki/Caf%C3%A9_au_lait_spot cafe-au-lait macules], clusters of freckles in unusual places, and problems with the bones, eyes and nervous system.<ref name="Ratner">PMID:25877329</ref> | + | Currently over 1485 mutations of <scene name='90/904315/Closed/3'>Neurofibromin</scene> have been identified that lead to life-threatening illnesses or conditions such as Neurofibromatosis Type I.<ref name="Lupton">PMID: 34887559 </ref> <ref name="Abramowicz">PMID:25182393</ref> Mutations to the NF1 gene that prevents the interaction of Neurofibromin with Ras, remove this check on Ras-dependent cell proliferation and uncontrolled cell growth can lead to tumors and a higher risk of cancer. [https://en.wikipedia.org/wiki/Neurofibromatosis_type_I Neurofibromatosis Type 1], the most well-known disease resulting from mutations in Neurofibromin, is characterized by cognitive impairment, soft, non-cancerous tumors on or under the skin known as neurofibromas, birthmarks called [https://en.wikipedia.org/wiki/Caf%C3%A9_au_lait_spot cafe-au-lait macules], clusters of freckles in unusual places, and problems with the bones, eyes and nervous system.<ref name="Ratner">PMID:25877329</ref> |
Neurofibromin is also involved in the differentiation of [https://en.wikipedia.org/wiki/Neural_crest neural crest-derived cells], [https://en.wikipedia.org/wiki/Mesenchymal_stem_cell mesenchymal cells], [https://en.wikipedia.org/wiki/Neural_stem_cell neural cells], [https://en.wikipedia.org/wiki/Melanocyte melanocytes], and [https://en.wikipedia.org/wiki/Osteocyte bone cells]. As Neurofibromin is essential for embryonic development, mutations to the NF1 gene can result in psychological retardation resulting from Type I neurofibromatosis. Most of the 1485 point mutations identified to lead to a synthesis of truncated, non-functional protein. Type I Neurofibromatosis is inherited in an autosomal dominant manner but about 50% of cases result from de novo mutations. <ref name="Abramowicz">PMID:25182393</ref> | Neurofibromin is also involved in the differentiation of [https://en.wikipedia.org/wiki/Neural_crest neural crest-derived cells], [https://en.wikipedia.org/wiki/Mesenchymal_stem_cell mesenchymal cells], [https://en.wikipedia.org/wiki/Neural_stem_cell neural cells], [https://en.wikipedia.org/wiki/Melanocyte melanocytes], and [https://en.wikipedia.org/wiki/Osteocyte bone cells]. As Neurofibromin is essential for embryonic development, mutations to the NF1 gene can result in psychological retardation resulting from Type I neurofibromatosis. Most of the 1485 point mutations identified to lead to a synthesis of truncated, non-functional protein. Type I Neurofibromatosis is inherited in an autosomal dominant manner but about 50% of cases result from de novo mutations. <ref name="Abramowicz">PMID:25182393</ref> |
Revision as of 02:16, 19 April 2022
This Sandbox is Reserved from February 28 through September 1, 2022 for use in the course CH462 Biochemistry II taught by R. Jeremy Johnson at the Butler University, Indianapolis, USA. This reservation includes Sandbox Reserved 1700 through Sandbox Reserved 1729. |
To get started:
More help: Help:Editing |
Human Neurofibromin - The Tumor Suppressor Gene
|
References
- ↑ 1.0 1.1 1.2 Trovo-Marqui AB, Tajara EH. Neurofibromin: a general outlook. Clin Genet. 2006 Jul;70(1):1-13. doi: 10.1111/j.1399-0004.2006.00639.x. PMID:16813595 doi:http://dx.doi.org/10.1111/j.1399-0004.2006.00639.x
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 Naschberger A, Baradaran R, Rupp B, Carroni M. The structure of neurofibromin isoform 2 reveals different functional states. Nature. 2021 Nov;599(7884):315-319. doi: 10.1038/s41586-021-04024-x. Epub 2021, Oct 27. PMID:34707296 doi:http://dx.doi.org/10.1038/s41586-021-04024-x
- ↑ 3.0 3.1 Lupton CJ, Bayly-Jones C, D'Andrea L, Huang C, Schittenhelm RB, Venugopal H, Whisstock JC, Halls ML, Ellisdon AM. The cryo-EM structure of the human neurofibromin dimer reveals the molecular basis for neurofibromatosis type 1. Nat Struct Mol Biol. 2021 Dec;28(12):982-988. doi: 10.1038/s41594-021-00687-2., Epub 2021 Dec 9. PMID:34887559 doi:http://dx.doi.org/10.1038/s41594-021-00687-2
- ↑ 4.0 4.1 4.2 Ratner N, Miller SJ. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer. 2015 May;15(5):290-301. doi: 10.1038/nrc3911. Epub 2015 Apr 16. PMID:25877329 doi:http://dx.doi.org/10.1038/nrc3911
- ↑ 5.0 5.1 5.2 Abramowicz A, Gos M. Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease. Dev Period Med. 2014 Jul-Sep;18(3):297-306. PMID:25182393
- ↑ Bergoug M, Doudeau M, Godin F, Mosrin C, Vallee B, Benedetti H. Neurofibromin Structure, Functions and Regulation. Cells. 2020 Oct 27;9(11). pii: cells9112365. doi: 10.3390/cells9112365. PMID:33121128 doi:http://dx.doi.org/10.3390/cells9112365